the Effect of Carbetocin in Decreasing Intraoperative Blood Loss in Abdominal Myomectomy

Inclusion Criteria: * • Patients presenting for abdominal myomectomy with documented uterine fibroids on pelvic imaging * Age ≥ 25 years and ≤ 50 years * Pre-operative hemoglobin \>10 g/dl * Ability to understand and the willingness to sign a written informed consent. * Admissible medical/surgical history * Five or less symptomatic uterine myomas * symptomatic stage 3 to 6 fibroids, according to FIGO staging Exclusion Criteria: * • Post-menopausal women * Patients with known bleeding/clotting disorders * Patients with a history of gynecologic malignancy * Hypertension. * Cardiac and Pulmonary diseases. * History of allergic reactions attributed to carbetocin